This review found no evidence to support the use of structured discharge processes in patients with communityacquired pneumonia. The conclusions appropriately reflect the limited evidence found.
Study selection
Randomised controlled trials (RCTs) and quasi-experimental studies of structured discharge from hospital for patients with community-acquired pneumonia were eligible. Structured discharge was defined to include interventions such as early patient engagement, patient-caregiver dyad intervention, transitional care, co-ordinated care and a multidisciplinary team approach. The comparator was usual care. Trials had to report hospital readmissions, emergency department visits or unscheduled visits to a healthcare provider after discharge. Details of interventions in included studies varied but all of them included medication reconciliation and follow-up telephone calls. Patients were generally aged over 65 years. All the trials were in USA or Canada.
The authors did not state how many reviewers selected studies for the review.
Assessment of study quality
Two independent reviewers assessed quality using the Joanna Briggs Institute critical appraisal tool. Discrepancies were resolved with the help of a third reviewer.
Data extraction
Data were extracted using a standardised form from the Joanna Briggs Institute. Data on numbers of participants and events were used to calculate odds ratios and 95% confidence intervals for each outcome.
The authors did not report how many reviewers performed data extraction.
Methods of synthesis
A narrative synthesis was presented.
Results of the review
Three studies were included: two RCTs (69 participants) and one quasi-RCT (146 participants). The RCTs met all quality criteria except that outcome assessors were not blinded in one trial. None of the trials reported a statistically significant difference between the structured discharge and control groups for any of the outcomes measured (readmission at 30, 90 or 180 days or emergency department visits at 30 days). Unscheduled visits to healthcare providers were not reported in any of the trials.
